Marex Group Résultats passés
Passé contrôle des critères 5/6
Marex Group a connu une croissance annuelle moyenne de ses bénéfices de 34.9%, tandis que le secteur Capital Markets a vu ses bénéfices augmenter de en hausse à 6.1% par an. Les revenus ont augmenté de en hausse à un taux moyen de 25.8% par an. Le rendement des capitaux propres de Marex Group est 25.8% et ses marges nettes sont de 10.2%.
Informations clés
34.90%
Taux de croissance des bénéfices
38.58%
Taux de croissance du BPA
| Capital Markets Croissance de l'industrie | 10.26% |
| Taux de croissance des recettes | 25.76% |
| Rendement des fonds propres | 25.82% |
| Marge nette | 10.22% |
| Dernière mise à jour des bénéfices | 31 Mar 2026 |
Mises à jour récentes des performances passées
Recent updates
Marex Group: Strong Growth, Cheap Valuation, But Still A Volatility-Driven Story
Summary Marex Group plc (MRX) delivered strong Q1 results, with revenues up 48% and adjusted profit before tax up 59%, driven by volatility in energy and metals. MRX's forward P/E of 11.5x and high 22.1% operating margin position it attractively versus peers, despite a cyclical, volatility-dependent business model. Revenue diversification into clearing, securities, and solutions segments reduces reliance on commodities, but future growth remains sensitive to macroeconomic cycles. Key risks include interest rate declines, slower client balance growth, integration of WEBB Traders, and potential operational disruptions from the Bermuda headquarters move. Read the full article on Seeking Alpha
MRX: Higher Margins And Q1 2026 Outlook Will Support Measured Upside
Analysts have lifted Marex Group's price target from $50.29 to $55.00 as they now factor in a higher profit margin of about 20.9% and a lower future P/E of roughly 9.7, despite softer revenue growth assumptions and a slightly higher discount rate. What's in the News Marex Group issued earnings guidance for the first quarter ended March 31, 2026, with expected revenues in a range of $667 million to $697 million, compared with Q1 2025 revenues of $467 million (Key Developments).
MRX: Higher Fair Value And Lower Future P/E Will Support Upside
Analysts have lifted their fair value estimate for Marex Group from $61.00 to $66.00, citing updated assumptions for modest positive revenue growth, a slightly higher profit margin, and a lower future P/E of 11.40 compared with the prior 13.35. What's in the News Marex Group issued earnings guidance for the quarter ending March 31, 2026, with expected revenues in a range of $667 million to $697 million, compared with Q1 2025 revenues of $467 million (Key Developments).
MRX: Rich Earnings Multiple Will Face Test From Softer Revenue Outlook
Analysts have inched their price targets for Marex Group higher by a few dollars into the mid $40s, reflecting updated views on revenue trends, margins, and a lower forward P/E assumption in recent TD Cowen, Piper Sandler, and Barclays research. Analyst Commentary Recent research reflects a mixed tone, with some optimism on Marex Group's revenue and margin outlook, alongside more cautious views on where the shares should trade relative to sector peers.MRX: Volatility And Trading Volumes Will Test Fairly Priced Shares
Analysts have lifted their average price target on Marex Group by mid single digits. Recent moves include $7 and $5 increases, citing updated assumptions for revenue trends, profit margins, and a lower implied future P/E multiple despite a slightly higher discount rate.MRX: Higher Trading Volumes And Supportive P/E Will Drive Future Upside
Analysts have lifted their average price target on Marex Group to $61, citing updated views on revenue trajectory, profit margins, and a modestly higher future P/E multiple informed by recent Street research revisions from TD Cowen, Piper Sandler, and Barclays. Analyst Commentary Bullish analysts are leaning into Marex Group's execution by lifting their individual price targets, which helps explain the higher Street average.MRX: Rising Trading Volumes And Volatility Will Support Earnings Power
Narrative update on Marex Group Analysts have nudged their Marex Group price targets higher by $7 and $5 in recent updates, while one cut a target by $1 to $49. These changes reflect adjusted views on volumes, volatility, and earnings potential rather than a change to our $61 fair value estimate.MRX: Higher Volatility And Volumes Will Support Earnings Power Going Forward
The analyst price target for Marex Group has increased from $56 to $61, with analysts citing updated views on revenue trends, profit margins, and future P/E assumptions reflected in recent research from TD Cowen, Piper Sandler, and Barclays. Analyst Commentary Recent research updates show bullish analysts lifting their fair value estimates for Marex Group, with the latest round of work incorporating refreshed views on revenue trends, margin resilience, and P/E assumptions.MRX: US Expansion And Higher Trading Volumes Will Support Future Upside
Analysts have raised their price targets on Marex Group, reflecting a revised fair value estimate from $47.71 to $50.29 as they factor in updated expectations around volumes, revenue trends, margins, and future P/E assumptions following recent sector research. Analyst Commentary Recent research updates on Marex Group show a mix of optimism and caution as analysts refresh their models ahead of upcoming results and sector comparisons.MRX: Rising Trading Activity Will Support Earnings Power Despite Slight Price Trim
Analysts have trimmed their price target on Marex Group to US$49 from US$50, citing refreshed views on sector volumes and volatility while keeping fair value and key valuation inputs broadly unchanged. Analyst Commentary Bullish analysts are treating the lower US$49 price target as a fine tuning rather than a reset, keeping their broader view on Marex Group intact while they refresh assumptions for sector activity.MRX Will Benefit From Expanding US Structured Products And Margin Resilience
Analysts have trimmed their price target on Marex Group by 4 percent to $56.00, citing slightly higher discount rates and weaker revenue growth expectations, partly offset by improved profit margin forecasts and a more attractive forward earnings multiple. What's in the News Marex Group launched a US structured products business targeting RIAs, broker dealers, and private banks.MRX: US Expansion Will Drive Future Upside Despite Pending Securities Lawsuits
Narrative Update on Marex Group Price Target Analysts have modestly reduced their averaged price target on Marex Group from approximately $49.00 to about $47.70. This reflects slightly weaker top line growth assumptions, partially offset by expectations for improved profit margins and a marginally lower future price to earnings multiple.MRX: Diversified US Expansion Will Drive Recovery Despite Securities Lawsuit Risk
Analysts have raised their price target for Marex Group from $47.67 to $49.00, citing updated assumptions around profit margins and discount rates, which support a modestly higher valuation. What's in the News Marex Group has launched its structured products business in the United States, led by Scott Kerbel.MRX: Revenue Outlook Will Support Rebound Despite Ongoing Class Action Lawsuits
Analysts have made a minor upward adjustment to the price target for Marex Group, now set at $47.67. This change is based on slight improvements in the revenue growth outlook and a stable discount rate.Analysts Lower Marex Group Price Target Amid Accounting Allegations and Revised Profit Outlook
Analysts have slightly lowered their price target for Marex Group from $49.33 to $47.67. This change reflects recent updates to the company’s growth and profitability outlook.Digitalization And M&A Will Unlock Global Market Potential
Analysts have lowered their price target for Marex Group from $50.89 to $49.33, citing slightly reduced profit margin forecasts and modestly improved revenue growth projections. What's in the News NINGI Research disclosed a short position in Marex Group, alleging the company used opaque off-balance-sheet entities, fictitious transactions, and misleading disclosures to obscure losses and inflate profits (Periodical).Here's Why Marex Group (NASDAQ:MRX) Has Caught The Eye Of Investors
NasdaqGS:MRX 1 Year Share Price vs Fair Value Explore Marex Group's Fair Values from the Community and select yours...
Acquisitions Will Fuel APAC And Middle East Expansion
Strong market share gains and acquisition integration are driving revenue growth and expanding product offerings and geographic reach.Further Upside For Marex Group plc (NASDAQ:MRX) Shares Could Introduce Price Risks After 26% Bounce
Marex Group plc ( NASDAQ:MRX ) shareholders have had their patience rewarded with a 26% share price jump in the last...Many Still Looking Away From Marex Group plc (NASDAQ:MRX)
When close to half the companies in the United States have price-to-earnings ratios (or "P/E's") above 19x, you may...Ventilation des recettes et des dépenses
Comment Marex Group gagne et dépense de l'argent. Sur la base des derniers bénéfices déclarés, sur une base LTM.
Historique des gains et des recettes
| Date | Recettes | Les revenus | Dépenses G+A | Dépenses de R&D |
|---|---|---|---|---|
| 31 Mar 26 | 3,266 | 334 | 1,386 | 0 |
| 31 Dec 25 | 2,870 | 294 | 1,250 | 0 |
| 30 Sep 25 | 2,668 | 266 | 1,156 | 0 |
| 30 Jun 25 | 2,608 | 251 | 1,105 | 0 |
| 31 Mar 25 | 2,530 | 234 | 1,052 | 0 |
| 31 Dec 24 | 2,357 | 205 | 990 | 0 |
| 30 Sep 24 | 2,142 | 189 | 939 | 0 |
| 30 Jun 24 | 1,883 | 134 | 1,283 | 0 |
| 31 Mar 24 | 1,849 | 140 | 1,028 | 0 |
| 31 Dec 23 | 1,882 | 128 | 799 | 0 |
| 30 Sep 23 | 1,092 | 140 | 737 | 0 |
| 30 Jun 23 | 1,818 | 139 | 451 | 0 |
| 31 Mar 23 | 1,570 | 115 | 451 | 0 |
| 01 Jan 23 | 1,010 | 92 | 459 | 0 |
| 01 Jan 22 | 825 | 57 | 371 | 0 |
| 31 Dec 20 | 758 | 44 | 277 | 0 |
| 31 Dec 19 | 549 | 36 | 212 | 0 |
| 31 Dec 18 | 384 | 10 | 0 | 0 |
| 31 Dec 17 | 318 | 18 | 0 | 0 |
| 31 Dec 16 | 328 | 20 | 0 | 0 |
| 31 Dec 15 | 346 | 18 | 0 | 0 |
Des revenus de qualité: MRX a des bénéfices de haute qualité.
Augmentation de la marge bénéficiaire: Les marges bénéficiaires nettes actuelles de MRX sont plus élevées que l'année dernière MRX. (10.2%) sont plus élevées que l'année dernière (9.2%).
Analyse des flux de trésorerie disponibles par rapport aux bénéfices
Analyse de la croissance passée des bénéfices
Tendance des revenus: Les bénéfices de MRX ont augmenté de manière significative de 34.9% par an au cours des 5 dernières années.
Accélération de la croissance: La croissance des bénéfices de MRX au cours de l'année écoulée ( 42.9% ) dépasse sa moyenne sur 5 ans ( 34.9% par an).
Bénéfices par rapport au secteur d'activité: La croissance des bénéfices MRX au cours de l'année écoulée ( 42.9% ) a dépassé celle du secteur Capital Markets 37.2%.
Rendement des fonds propres
ROE élevé: Bien que le retour sur capitaux propres ( 25.82% ) de MRX soit élevé, cette mesure est faussée en raison de son niveau d'endettement élevé.
Rendement des actifs
Rendement des capitaux employés
Découvrir des entreprises performantes dans le passé
Analyse de l'entreprise et données financières
| Données | Dernière mise à jour (heure UTC) |
|---|---|
| Analyse de l'entreprise | 2026/05/21 08:16 |
| Cours de l'action en fin de journée | 2026/05/21 00:00 |
| Les revenus | 2026/03/31 |
| Revenus annuels | 2025/12/31 |
Sources de données
Les données utilisées dans notre analyse de l'entreprise proviennent de S&P Global Market Intelligence LLC. Les données suivantes sont utilisées dans notre modèle d'analyse pour générer ce rapport. Les données sont normalisées, ce qui peut entraîner un délai avant que la source ne soit disponible.
| Paquet | Données | Cadre temporel | Exemple de source américaine * |
|---|---|---|---|
| Finances de l'entreprise | 10 ans |
| |
| Estimations consensuelles des analystes | +3 ans |
|
|
| Prix du marché | 30 ans |
| |
| Propriété | 10 ans |
| |
| Gestion | 10 ans |
| |
| Principaux développements | 10 ans |
|
* Exemple pour les titres américains ; pour les titres non américains, des formulaires réglementaires et des sources équivalentes sont utilisés.
Sauf indication contraire, toutes les données financières sont basées sur une période annuelle mais mises à jour trimestriellement. C'est ce qu'on appelle les données des douze derniers mois (TTM) ou des douze derniers mois (LTM). En savoir plus.
Modèle d'analyse et flocon de neige
Les détails du modèle d’analyse utilisé pour générer ce rapport sont disponibles sur notre page Github; nous proposons également des guides expliquant comment utiliser nos rapports et des tutoriels sur Youtube.
Découvrez l'équipe de classe mondiale qui a conçu et construit le modèle d'analyse Simply Wall St.
Indicateurs de l'industrie et du secteur
Nos indicateurs de secteur et de section sont calculés toutes les 6 heures par Simply Wall St. Les détails de notre processus sont disponibles sur Github.
Sources des analystes
Marex Group plc est couverte par 13 analystes. 7 de ces analystes ont soumis les estimations de revenus ou de bénéfices utilisées comme données d'entrée dans notre rapport. Les soumissions des analystes sont mises à jour tout au long de la journée.
| Analyste | Institution |
|---|---|
| Benjamin Budish | Barclays |
| Christopher Allen | Citigroup Inc |
| Alexander Blostein | Goldman Sachs |